Erratum: Autonomic imbalance as a predictor of metabolic risks, cardiovascular disease, diabetes, and mortality (J Clin Endocrinol Metab. (2015) 100:6 (2443-2448) DOI: 10.1210/jc.2015-1748);Autonomic imbalance as a predictor of metabolic risks, cardiovascular disease, diabetes, and mortality

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 6, 2015, Pages 2443-2448

  Wulsin, Lawson R ^a   Horn, Paul S ^a   Perry, Jennifer L ^a   Massaro, Joseph M ^b   D'Agostino, Ralph B ^c  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c Boston University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGE; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BLOOD PRESSURE; BODY MASS; CARDIOMETABOLIC RISK; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HEART RATE VARIABILITY; HUMAN; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESTING HEART RATE; SEX; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; AGED; AUTONOMIC NEUROPATHY; CARDIOVASCULAR DISEASES; COMPLICATION; HEART RATE; METABOLIC SYNDROME X; PATHOPHYSIOLOGY; PROGNOSIS; RISK FACTOR; YOUNG ADULT;

ADULT; AGED; AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; FEMALE; HEART RATE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; PROGNOSIS; RISK FACTORS; YOUNG ADULT;

EID: 84930813947     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2016-1833     Document Type: Erratum

References (14)

1. Alberti KG. Impaired glucose tolerance: What are the clinical implications? Diabetes Res Clin Pract. 1998;40 Suppl:S3-S8.
2. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640-1645.
3. McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care. 2005;28:385-390.
4. Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in united states adults. Circulation. 2004;110:1245-1250.
5. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: Time for a critical appraisal: Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2005;28:2289-2304.
6. Reaven GM. The metabolic syndrome: Time to get off the merry-go-round? J Intern Med. 2011;269:127-136.
7. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-1607.
8. Reaven GM. Compensatory hyperinsulinemia and the development of an atherogenic lipoprotein profile: The price paid to maintain glucose homeostasis in insulin-resistant individuals. Endocrinol Metab Clin North Am. 2005;34:49-62.
9. Thayer JF, Yamamoto SS, Brosschot JF. The relationship of autonomic imbalance, heart rate variability and cardiovascular disease risk factors. Int J Cardiol. 2010;141:122-131.
10. Freeman R. Assessment of cardiovascular autonomic function. Clin Neurophysiol. 2006;117:716-730.
11. Franco OH, Massaro JM, Civil J, Cobain MR, O'Malley B, D'Agostino RB, Sr. Trajectories of entering the metabolic syndrome: The Framingham Heart Study. Circulation. 2009;120:1943-1950.
12. Licht CM, Vreeburg SA, van Reedt Dortland AK, et al. Increased sympathetic and decreased parasympathetic activity rather than changes in hypothalamic-pituitary-adrenal axis activity is associated with metabolic abnormalities. J Clin Endocrinol Metab. 2010;95:2458-2466.
13. Licht CM, de Geus EJ, Penninx BW. Dysregulation of the autonomic nervous system predicts the development of the metabolic syndrome. J Clin Endocrinol Metab. 2013;98:2484-2493.
14. Ford ES, Mokdad AH, Giles WH. Trends in waist circumference among U.S. Adults. Obes Res. 2003;11:1223-1231.